               SEQUENCE LISTING

<110> Imperial Innovations Limited

<120> Drug Delivery

<130> P025658GB

<160> 7

<170> BiSSAP 1.3.6

<210> 1
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<220> 
<221> SITE
<222> 4
<223> D-Phe

<400> 1
Arg Gly Asp Phe Cys 
1               5   

<210> 2
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<220> 
<221> SITE
<222> 4
<223> D-Phe

<400> 2
Arg Ala Asp Phe Cys 
1               5   

<210> 3
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 3
Gly Arg Gly Asp Ser 
1               5   

<210> 4
<211> 6
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 4
Gly Arg Gly Asp Ser Pro 
1               5       

<210> 5
<211> 36
<212> DNA
<213> Artificial Sequence


<220> 
<223> aptamer

<400> 5
agggccacgt ctatttagac tagagtgcag tggttc                               36


<210> 6
<211> 24
<212> DNA
<213> Artificial Sequence


<220> 
<223> antisense probe for aptamer

<220> 
<221> modified_base
<222> 24
<223> /mod_base="OTHER"
      /note="fluorochrome IRD 700"

<400> 6
taaatctgat ctcaggtcac caag                                           24


<210> 7
<211> 12
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 7
Lys Cys Gly Pro Gln Gly Ile Trp Gly Gln Cys Lys 
1               5                   10          

